Keck Medicine begins enrollment in phase 3 trial for COVID-19 antibody treatment

Monoclonal antibodies made headlines in early October when President Donald Trump was treated for COVID-19 with an experimental monoclonal antibody drug made by Regeneron.

As part of a nationwide effort to discover more about the effects of this kind of therapy, Read More »

November 16th, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|

Your guide to a COVID-19 vaccine: What the public needs to know

News about a potential COVID-19 vaccine is announced almost daily, leading people to wonder when a vaccine will be available, and whether it will be safe. Edward Jones-Lopez, MD, MS, a Keck Medicine of USC infectious diseases expert and Read More »

October 26th, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|

Clinical trial looks at deep brain stimulation for mild Alzheimer’s

An estimated 5.5 million people in the United States live with Alzheimer’s disease, which is the most common form of dementia.

Keck Medicine of USC is enrolling individuals in an international Phase 3 clinical trial to examine Read More »

October 21st, 2020|Announcements, Clinical Studies, Keck Net Intranet|

Filling the gap in neonatal care with play

When babies are born early — at or before 32 weeks — they are at risk for challenges, including developmental and learning disabilities. While they receive lots of care in a neonatal intensive care unit (NICU), there’s about Read More »

September 16th, 2020|Announcements, Clinical Studies|

Scientists receive grant to research novel approach for treating painful pelvic disorder

Larissa Rodriguez, MD, professor of urology and obstetrics and gynecology at the Keck School of Medicine of USC, and Jason Kutch, PhD, associate professor at the USC Division of Biokinesiology and Physical Therapy, Read More »

August 26th, 2020|Announcements, Clinical Studies, Keck Net Intranet|